Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Borghesi

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
European Urology|September 20, 2015
Re: Sabine D. Brookman-May, Matthias May, Ingmar Wolff, et al. Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1-pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA Project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors? Eur Urol 2015;67:943-51Marco Borghesi, Gaetano La Manna, Riccardo Schiavina
European Urology|October 6, 2012
Words of wisdom. Re: Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of Medicare-age menVincenzo Ficarra, Marco Borghesi, Giacomo Novara, et al.
Clinical Genitourinary Cancer|October 23, 2012
Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and managementMarco Borghesi, Eugenio Brunocilla, Riccardo Schiavina, et al.
Frontiers in Oncology|July 26, 2022
Editorial: Biomarkers in Genitourinary Cancers, Volume IPaula Alexandra Videira, Marco Borghesi, Eric A Singer
Clinical Genitourinary Cancer|December 17, 2013
Lymphovascular invasion in high grade T1 bladder cancer: are more aggressive treatments needed?Marco Borghesi, Eugenio Brunocilla, Riccardo Schiavina, et al.
Clinical Genitourinary Cancer|December 17, 2013
Clinically localized renal cell carcinoma: which is the best treatment strategy?Marco Borghesi, Eugenio Brunocilla, Riccardo Schiavina, et al.
Clinical Genitourinary Cancer|December 18, 2013
Robot-assisted radical nephroureterectomy for upper urinary tract urothelial carcinoma: a promising alternative to open surgery or a future "gold standard"?Marco Borghesi, Eugenio Brunocilla, Riccardo Schiavina, et al.
The Journal of Urology|March 26, 2013
Re: impact of complete bladder neck preservation on urinary continence, quality of life and surgical margins after radical prostatectomy: a randomized, controlled, single blind trial: J. N. Nyarangi-Dix, J. P. Radtke, B. Hadaschik, S. Pahernik and M. Hohenfellner J Urol 2013; 189: 891-898Eugenio Brunocilla, Cristian Vincenzo Pultrone, Marco Borghesi, et al.
Urologia|April 19, 2014
[Predictors of positive surgical margins after nephron-sparing surgery for renal cell carcinoma: retrospective analysis on 298 consecutive patients]Riccardo Schiavina, Marco Borghesi, Francesco Chessa, et al.
European Urology|December 3, 2013
Re: long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapyRiccardo Schiavina, Eugenio Brunocilla, Marco Borghesi, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
European Urology|September 20, 2015
Re: Sabine D. Brookman-May, Matthias May, Ingmar Wolff, et al. Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1-pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA Project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors? Eur Urol 2015;67:943-51Marco Borghesi, Gaetano La Manna, Riccardo Schiavina
European Urology|October 6, 2012
Words of wisdom. Re: Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of Medicare-age menVincenzo Ficarra, Marco Borghesi, Giacomo Novara, et al.
Clinical Genitourinary Cancer|October 23, 2012
Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and managementMarco Borghesi, Eugenio Brunocilla, Riccardo Schiavina, et al.
Frontiers in Oncology|July 26, 2022
Editorial: Biomarkers in Genitourinary Cancers, Volume IPaula Alexandra Videira, Marco Borghesi, Eric A Singer
Clinical Genitourinary Cancer|December 17, 2013
Lymphovascular invasion in high grade T1 bladder cancer: are more aggressive treatments needed?Marco Borghesi, Eugenio Brunocilla, Riccardo Schiavina, et al.
Clinical Genitourinary Cancer|December 17, 2013
Clinically localized renal cell carcinoma: which is the best treatment strategy?Marco Borghesi, Eugenio Brunocilla, Riccardo Schiavina, et al.
Clinical Genitourinary Cancer|December 18, 2013
Robot-assisted radical nephroureterectomy for upper urinary tract urothelial carcinoma: a promising alternative to open surgery or a future "gold standard"?Marco Borghesi, Eugenio Brunocilla, Riccardo Schiavina, et al.
The Journal of Urology|March 26, 2013
Re: impact of complete bladder neck preservation on urinary continence, quality of life and surgical margins after radical prostatectomy: a randomized, controlled, single blind trial: J. N. Nyarangi-Dix, J. P. Radtke, B. Hadaschik, S. Pahernik and M. Hohenfellner J Urol 2013; 189: 891-898Eugenio Brunocilla, Cristian Vincenzo Pultrone, Marco Borghesi, et al.
Urologia|April 19, 2014
[Predictors of positive surgical margins after nephron-sparing surgery for renal cell carcinoma: retrospective analysis on 298 consecutive patients]Riccardo Schiavina, Marco Borghesi, Francesco Chessa, et al.
European Urology|December 3, 2013
Re: long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapyRiccardo Schiavina, Eugenio Brunocilla, Marco Borghesi, et al.
Pageof 18